Viewing Study NCT02348359


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-02-06 @ 12:57 AM
Study NCT ID: NCT02348359
Status: TERMINATED
Last Update Posted: 2022-02-11
First Post: 2015-01-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: X-82 to Treat Age-related Macular Degeneration
Sponsor: Tyrogenex
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age-Related Macular Degeneration (AMD) View
None Macular Degeneration View
None Exudative Age-related Macular Degeneration View
None AMD View
None Macular Degeneration, Age-related, 10 View
None Eye Diseases View
None Retinal Degeneration View
None Retinal Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vascular Endothelial Growth Factor (VEGF) View
None Platelet Derived Growth Factor (PDGF) View
None AMD View